Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Quality Control Testing of MDIs

Posted on By

SOP for Quality Control Testing of MDIs

Quality Assurance Procedures for MDIs

1) Purpose

The purpose of this SOP is to establish the procedures for quality control testing of metered-dose inhalers (MDIs) to ensure they meet the required specifications and regulatory standards.

2) Scope

This SOP applies to all quality control personnel involved in testing MDIs at the manufacturing facility, including chemists and laboratory technicians.

3) Responsibilities

The responsibilities for this SOP include conducting tests accurately, documenting results, and ensuring compliance with established standards. Specific roles include:
Chemists: Perform the quality control tests as specified.
Laboratory Technicians: Assist in sample preparation and testing.
Quality Control Supervisors: Review and approve test results and documentation.

See also  SOP for Environmental Monitoring in MDI Production

4) Procedure

4.1 Sample Collection
4.1.1 Collect samples from each batch of MDIs following the sampling plan.
4.1.2 Label and record the samples appropriately.
4.2 Physical Tests
4.2.1 Inspect the MDIs for visual defects.
4.2.2 Measure the weight and dimensions of the MDIs.
4.3 Chemical Tests
4.3.1 Perform assays to determine the active ingredient content.
4.3.2 Conduct impurity profiling to ensure product purity.
4.4 Performance Tests
4.4.1 Test

the aerosol performance, including dose uniformity and spray pattern.
4.4.2 Measure the particle size distribution using appropriate techniques.
4.5 Microbial Tests
4.5.1 Conduct microbial limit tests to ensure the product is free from harmful microorganisms.
4.5.2 Perform sterility tests as required.
4.6 Documentation
4.6.1 Record all test results in the quality control logbook.
4.6.2 Review and approve the test results and ensure they meet the acceptance criteria.

See also  SOP for Warehouse Management for MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler

6) Documents, if any

Quality control test reports, sample collection records, and laboratory notebooks should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for quality control testing standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Validation of Analytical Methods for Transdermal Patches
Next Post: SOP for Final Product Inspection for Lotions

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version